NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,072 filers reported holding NOVARTIS A G in Q3 2021. The put-call ratio across all filers is 0.22 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $236,433 | +0.9% | 2,321 | 0.0% | 0.05% | +4.5% |
| Q2 2023 | $234,228 | +9.0% | 2,321 | -0.7% | 0.04% | +2.3% |
| Q1 2023 | $214,967 | +3.1% | 2,337 | +1.7% | 0.04% | -4.4% |
| Q4 2022 | $208,434 | +3.7% | 2,298 | -3.2% | 0.04% | -13.5% |
| Q2 2022 | $201,000 | -16.9% | 2,373 | -13.9% | 0.05% | -7.1% |
| Q1 2022 | $242,000 | -4.3% | 2,755 | -4.8% | 0.06% | -3.4% |
| Q4 2021 | $253,000 | +24.6% | 2,893 | +30.1% | 0.06% | +5.5% |
| Q2 2021 | $203,000 | -14.3% | 2,224 | -19.9% | 0.06% | -22.5% |
| Q1 2021 | $237,000 | -30.1% | 2,776 | -22.7% | 0.07% | -35.5% |
| Q4 2020 | $339,000 | +25.1% | 3,593 | +3.5% | 0.11% | +7.8% |
| Q3 2020 | $271,000 | -12.6% | 3,473 | -2.3% | 0.10% | -19.0% |
| Q2 2020 | $310,000 | +4.0% | 3,553 | +6.9% | 0.13% | -3.8% |
| Q1 2020 | $298,000 | -3.2% | 3,323 | +2.3% | 0.13% | +15.9% |
| Q4 2019 | $308,000 | – | 3,249 | – | 0.11% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GODSEY & GIBB, INC | 184,900 | $15,121,000 | 6.74% |
| Martin Investment Management, LLC | 289,924 | $23,710,000 | 5.98% |
| Camber Capital Management LP | 2,000,000 | $163,560,000 | 5.04% |
| MANAGED ASSET PORTFOLIOS, LLC | 381,778 | $31,222,000 | 4.76% |
| PROFESSIONAL ADVISORY SERVICES INC | 267,779 | $21,899,000 | 3.22% |
| SCHARF INVESTMENTS, LLC | 1,244,711 | $101,794,000 | 3.21% |
| GARLAND CAPITAL MANAGEMENT INC | 50,755 | $4,151,000 | 2.97% |
| First Fiduciary Investment Counsel, Inc. | 167,378 | $13,688,000 | 2.67% |
| WILKINS INVESTMENT COUNSEL INC | 130,590 | $10,680,000 | 2.61% |
| Lowell Blake & Associates Inc. | 66,309 | $5,423,000 | 2.52% |